Implementation of the Cass Review resulted in gonadatrophin releasing hormone (GnRH) analogues (puberty blockers) no longer being available to patients under the age of 18 in England and Wales via the National Health Service (NHS).
Group seeks Judicial Review of Ban on Private…
Implementation of the Cass Review resulted in gonadatrophin releasing hormone (GnRH) analogues (puberty blockers) no longer being available to patients under the age of 18 in England and Wales via the National Health Service (NHS).